 Sanofi SA NASDAQ: SNY and GSK plc NYSE: GSK have announced positive data from their vaccine trial of adjuvanted bivalent D614 and Beta B.1.351 vaccine candidate. Sanofi-GSKs vaccine is the first candidate to demonstrate efficacy in a placebo-. 